2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …

M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

[HTML][HTML] Extracellular vesicles DJ-1 derived from hypoxia-conditioned hMSCs alleviate cardiac hypertrophy by suppressing mitochondria dysfunction and preventing …

Y Lu, J Zhang, B Han, Y Yu, W Zhao, T Wu… - Pharmacological …, 2023 - Elsevier
Background As a pathological myocardial remodeling process in a variety of cardiovascular
diseases, cardiac hypertrophy still has no effective treatment. Human mesenchymal stem …

Single‐versus dual‐chamber implantable cardioverter‐defibrillator for primary prevention of sudden cardiac death in the United States

G Margolis, N Hamuda, O Kobo… - Journal of the …, 2023 - Am Heart Assoc
Background Routine addition of an atrial lead during an implantable cardioverter‐
defibrillator (ICD) implantation for primary prevention of sudden cardiac death, in patients …

Inter-American Society of Cardiology (CIFACAH-ELECTROSIAC) and Latin-American Heart Rhythm Society (LAHRS): Multidisciplinary review on the appropriate use …

JE Gómez-Mesa, M Márquez-Murillo… - Journal of Interventional …, 2023 - Springer
Background Our main objective was to present a multidisciplinary review on the
epidemiology of sudden cardiac death (SCD) and the tools that could be used to identify …

Sex difference and outcome trends following transcatheter aortic valve replacement

G Elbaz-Greener, E Rahamim, Z Abu Ghosh… - Frontiers in …, 2022 - frontiersin.org
Background Based on worldwide registries, approximately 50% of patients who underwent
transcatheter aortic valve replacement (TAVR) are female patients. Although TAVR …

Safety and in-hospital outcomes of transvenous lead extraction for cardiac implantable device–related infections: analysis of 13 years of inpatient data in the United …

SM Hosseini, G Rozen, MI Kaadan, J Galvin… - JACC: Clinical …, 2019 - jacc.org
Objectives: The aim of this study was to investigate the safety and in-hospital outcomes of
transcutaneous lead extraction (TLE) associated with device-related infection (DRI) in the …

Sex and race disparities in hypertrophic cardiomyopathy: unequal implantable cardioverter-defibrillator use during hospitalization

SH Patlolla, HV Schaff, RA Nishimura, JB Geske… - Mayo Clinic …, 2022 - Elsevier
Objective To evaluate if there are sex and race disparities in use of implantable cardioverter-
defibrillator (ICD) devices for prevention of sudden cardiac death in patients with …

[HTML][HTML] The obesity paradox in real-world nation-wide cohort of patients admitted for a stroke in the US

G Rozen, G Elbaz-Greener, G Margolis, I Marai… - Journal of Clinical …, 2022 - mdpi.com
Background: Obesity has been associated with increased incidence and severity of various
cardiovascular risk factors and increased risk for stroke. However, the evidence of its effect …

Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey

O Tovia-Brodie, MR Acha, B Belhassen, A Gasperetti… - Heart Rhythm, 2022 - Elsevier
Background Cardiac implantable electronic device (CIED) implantation rates as well as the
clinical and procedural characteristics and outcomes in patients with known active …

Guía ESC 2021 sobre estimulación cardiaca y terapia de resincronización

M Glikson, JC Nielsen, MB Kronborg… - Revista Española de …, 2022 - iris.unimore.it
Guía ESC 2021 sobre estimulación cardiaca y terapia de resincronización IRIS IRIS Home
Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English …